Gecina pre-lets the Biopark building in Paris’ 13th arrondissement
Gecina is delighted to welcome a group of leading biotechnology, digital and health companies to its Biopark building located in Paris’ 13th arrondissement. The firm nine-year lease covers all of the space in Building E, representing around 6,400 sq.m, which will be available to the tenant from September 1, 2021.
With the existing tenants Cellectis and Parexel International, the Biopark real estate complex is a specialist life sciences hub.
Biopark - Building E
Currently being redeveloped, Building E on Biopark real estate complex is an independent building designed with a focus on developing creativity. It is targeting the HQE and BiodiverCity labels and certification. Its delivery is scheduled for the second half of 2021.
The pre-letting of this entire project highlights the appetite among businesses for high-quality buildings located at the heart of Paris. With this transaction, Gecina is continuing to improve the pre-letting of its development pipeline, with 52% of the operations scheduled for delivery in 2021 and 2022 now let.
To safeguard its communications, Gecina certifies its contents with Wiztrust. You can check their authenticity at www.wiztrust.com.
Linked news
Contacts
-
-
Julien Landfried
Executive Director Communications, Public Affairs and Brand
